Peptide Receptor Radionuclide Therapy for a Phosphaturic Mesenchymal Tumor

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: Peptide Receptor Radionuclide Therapy for a Phosphaturic Mesenchymal Tumor ; volume:13 ; number:3 ; year:2020 ; pages:1373-1380
Case reports in oncology ; 13, Heft 3 (2020), 1373-1380

Creator: Häfliger, Simon
Seidel, Ann-Katrin
Schoch, Eric
Reichmann, Jan
Wild, Damian
Steinmann-Schwager, Stephanie
Pless, Miklos

DOI: 10.1159/000510334

URN: urn:nbn:de:101:1-2021011323221103441616

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:21 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Häfliger, Simon
Seidel, Ann-Katrin
Schoch, Eric
Reichmann, Jan
Wild, Damian
Steinmann-Schwager, Stephanie
Pless, Miklos

Other Objects (12)

Peptide receptor radionuclide therapy for sarcoidosis

Strategies Towards Improving Clinical Outcomes of Peptide Receptor Radionuclide Therapy

Apparent pacemaker dysfunction during peptide receptor radionuclide therapy for neuroendocrine tumor

Liver-Directed Therapy for Neuroendocrine Tumor Metastases in the Era of Peptide Receptor Radionuclide Therapy

Early response assessment and prediction of overall survival after peptide receptor radionuclide therapy

Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: predictors and pitfalls

Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy

Simplified dosimetry for kidneys and tumors in 177Lu-labeled peptide receptor radionuclide therapy

Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy

Pre-therapy Somatostatin-Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy

Pre-therapy somatostatin receptor-based heterogeneity predicts overall survival in pancreatic neuroendocrine tumor patients undergoing peptide receptor radionuclide therapy

Peptide receptor radionuclide therapy for sarcoidosis

Strategies Towards Improving Clinical Outcomes of Peptide Receptor Radionuclide Therapy

Apparent pacemaker dysfunction during peptide receptor radionuclide therapy for neuroendocrine tumor

Liver-Directed Therapy for Neuroendocrine Tumor Metastases in the Era of Peptide Receptor Radionuclide Therapy

Early response assessment and prediction of overall survival after peptide receptor radionuclide therapy

Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: predictors and pitfalls

Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy

Simplified dosimetry for kidneys and tumors in 177Lu-labeled peptide receptor radionuclide therapy

Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy

Pre-therapy Somatostatin-Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy

Pre-therapy somatostatin receptor-based heterogeneity predicts overall survival in pancreatic neuroendocrine tumor patients undergoing peptide receptor radionuclide therapy

Peptide receptor radionuclide therapy for sarcoidosis

Strategies Towards Improving Clinical Outcomes of Peptide Receptor Radionuclide Therapy

Apparent pacemaker dysfunction during peptide receptor radionuclide therapy for neuroendocrine tumor

Liver-Directed Therapy for Neuroendocrine Tumor Metastases in the Era of Peptide Receptor Radionuclide Therapy

Early response assessment and prediction of overall survival after peptide receptor radionuclide therapy

Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: predictors and pitfalls

Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy

Simplified dosimetry for kidneys and tumors in 177Lu-labeled peptide receptor radionuclide therapy

Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy

Pre-therapy Somatostatin-Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy

Pre-therapy somatostatin receptor-based heterogeneity predicts overall survival in pancreatic neuroendocrine tumor patients undergoing peptide receptor radionuclide therapy

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Peptide Receptor Radionuclide Therapy for a Phosphaturic Mesenchymal Tumor

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Peptide receptor radionuclide therapy for sarcoidosis

Strategies Towards Improving Clinical Outcomes of Peptide Receptor Radionuclide Therapy

Apparent pacemaker dysfunction during peptide receptor radionuclide therapy for neuroendocrine tumor

Liver-Directed Therapy for Neuroendocrine Tumor Metastases in the Era of Peptide Receptor Radionuclide Therapy

Early response assessment and prediction of overall survival after peptide receptor radionuclide therapy

Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: predictors and pitfalls

Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy

Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy

Simplified dosimetry for kidneys and tumors in 177Lu-labeled peptide receptor radionuclide therapy

Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy

Pre-therapy Somatostatin-Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy

Pre-therapy somatostatin receptor-based heterogeneity predicts overall survival in pancreatic neuroendocrine tumor patients undergoing peptide receptor radionuclide therapy

Peptide receptor radionuclide therapy for sarcoidosis

Strategies Towards Improving Clinical Outcomes of Peptide Receptor Radionuclide Therapy

Apparent pacemaker dysfunction during peptide receptor radionuclide therapy for neuroendocrine tumor

Liver-Directed Therapy for Neuroendocrine Tumor Metastases in the Era of Peptide Receptor Radionuclide Therapy

Early response assessment and prediction of overall survival after peptide receptor radionuclide therapy

Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: predictors and pitfalls

Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy

Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy

Simplified dosimetry for kidneys and tumors in 177Lu-labeled peptide receptor radionuclide therapy

Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy

Pre-therapy Somatostatin-Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy

Pre-therapy somatostatin receptor-based heterogeneity predicts overall survival in pancreatic neuroendocrine tumor patients undergoing peptide receptor radionuclide therapy

Peptide receptor radionuclide therapy for sarcoidosis

Strategies Towards Improving Clinical Outcomes of Peptide Receptor Radionuclide Therapy

Apparent pacemaker dysfunction during peptide receptor radionuclide therapy for neuroendocrine tumor

Liver-Directed Therapy for Neuroendocrine Tumor Metastases in the Era of Peptide Receptor Radionuclide Therapy

Early response assessment and prediction of overall survival after peptide receptor radionuclide therapy

Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: predictors and pitfalls

Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy

Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy

Simplified dosimetry for kidneys and tumors in 177Lu-labeled peptide receptor radionuclide therapy

Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy

Pre-therapy Somatostatin-Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy

Pre-therapy somatostatin receptor-based heterogeneity predicts overall survival in pancreatic neuroendocrine tumor patients undergoing peptide receptor radionuclide therapy

Related objects

Reset password